Testing effectiveness (Phase 2)Study completedNCT00071877
What this trial is testing
An Open-Label Clinical Trial of Replagal Enzyme Therapy in Children Ages 7-17 Years With Fabry Disease
Who this might be right for
Fabry Disease
National Institute of Neurological Disorders and Stroke (NINDS) 25